Arkolith/Insider Trading/VERA/Form 4

Turner William D.

Chief Regulatory OfficerVera Therapeutics, Inc. (VERA) · full profile →Form 4 · filed Dec 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$501K
Net Open-Market Flow
-$501K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Option exercise(M)10K$15.53$155K33K
Dec 15, 2025Sell(S)10K$50.08$501K23K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2025Option exercise(M)10K—$0245K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-322691) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML